Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Dexdor1件: Dexmedetomidine (Dexdor)1件: Dexmedetomidine (Dexdor (TN)) 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬4件: 2, 4, 6, 70 💬
2Dexmedetomidine
(Dexdor (TN))		1件: Dexmedetomidine (Dexdor)1件: Dexmedetomidine (Dexdor (TN)) 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬14件: 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
3Dexmedetomidine 1
(Dexdor (TN))		1件: Dexmedetomidine (Dexdor)1件: Dexmedetomidine (Dexdor (TN)) 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280 💬
4Dexmedetomidine 2
(Dexdor (TN))		1件: Dexmedetomidine (Dexdor)1件: Dexmedetomidine (Dexdor (TN)) 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280 💬
5Dexmedetomidine 3
(Dexdor (TN))		1件: Dexmedetomidine (Dexdor)1件: Dexmedetomidine (Dexdor (TN)) 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 280 💬
6Dexmedetomidine group
(Dexdor (TN))		1件: Dexmedetomidine (Dexdor)1件: Dexmedetomidine (Dexdor (TN)) 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 70 💬
7Dexmedetomidine Hcl 100 Mcg/mL Inj
(Dexdor (TN))		1件: Dexmedetomidine (Dexdor)1件: Dexmedetomidine (Dexdor (TN)) 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215 💬
8DEXMEDETOMIDINE HYDROCHLORIDE
(Dexdor (TN))		1件: Dexmedetomidine (Dexdor)1件: Dexmedetomidine (Dexdor (TN)) 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 70 💬
9Dexmedetomidine Hydrochloride Infusion
(Dexdor (TN))		1件: Dexmedetomidine (Dexdor)1件: Dexmedetomidine (Dexdor (TN)) 💬 3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 6 💬
10Dexmedetomidine with ropivacaine
(Dexdor (TN))		2件: Dexmedetomidine (Dexdor),
Ropivacaine		2件: Dexmedetomidine (Dexdor (TN)),
Ropivacaine 💬 		8件: ADRA2A,
ADRA2B,
ADRA2C,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬 		5件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬1件: 70 💬
11Fentanyl (Low Dose) + Dexmedetomidine
(Dexdor (TN))		2件: Dexmedetomidine (Dexdor),
Fentanyl		2件: Fentanyl ,
Dexmedetomidine (Dexdor (TN)) 💬 		4件: ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬 		4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215 💬
12Scopolamine, atropine, edaravone and dexmedetomidine
(Dexdor (TN))		4件: Atropine,
Dexmedetomidine (Dexdor),
Edaravone,
Scopolamine		4件: Atropine ,
Scopolamine ,
Dexmedetomidine (Dexdor (TN)),
Edaravone 💬 		8件: ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 2 💬